Glaukos (GKOS) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
16 Apr, 2026Executive summary
Annual meeting scheduled for May 28, 2026, with virtual attendance available for shareholders.
Shareholders are encouraged to review proxy materials and vote by May 27, 2026.
Voting matters and shareholder proposals
Election of two directors: Denice M. Torres and Aimee S. Weisner, both recommended by the board.
Advisory vote on the compensation of named executive officers.
Ratification of Ernst & Young LLP as independent registered public accounting firm for the year ending December 31, 2026.
Proxies may vote on other business that arises during the meeting or any adjournment.
Board of directors and corporate governance
Board recommends the election of the two nominated directors.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Glaukos
- Q1 2026 sales up 41% to $150.6M, guidance raised, driven by iDose TR and Epioxa launches.GKOS
Q1 202630 Apr 2026 - 2025 saw strong growth, robust governance, and ESG progress, with pay tied to performance.GKOS
Proxy filing16 Apr 2026 - Market-leading therapies and innovation fuel strong growth and pipeline expansion.GKOS
Investor presentation5 Mar 2026 - Record 2025 sales and Glaucoma growth drive strong 2026 outlook, despite impairment.GKOS
Q4 202518 Feb 2026 - Record revenue and margin gains driven by iDose, with Epioxa launch and payer expansion ahead.GKOS
Stephens Annual Investment Conference3 Feb 2026 - iDose launch accelerates interventional glaucoma shift, with full reimbursement and pipeline growth ahead.GKOS
2024 Truist Securities MedTech Conference3 Feb 2026 - Record Q2 sales and raised guidance highlight strong glaucoma growth despite wider net loss.GKOS
Q2 20242 Feb 2026 - iDose launch and pipeline innovation set the stage for long-term growth in ophthalmology.GKOS
The 44th Annual William Blair Growth Stock Conference1 Feb 2026 - iDose and iStent infinite drive growth as clinical adoption and coverage expand in 2025.GKOS
2024 Wells Fargo Healthcare Conference22 Jan 2026